Design of nanozymes for inflammatory bowel disease therapy

作     者：Chaoqun Cheng Sheng Zhao Yuan Cheng Yufeng Liu Hui Wei Chaoqun Cheng;Sheng Zhao;Yuan Cheng;Yufeng Liu;Hui Wei

作者机构：Department of Biomedical EngineeringCollege of Engineering and Applied SciencesNanjing National Laboratory of MicrostructuresJiangsu Key Laboratory of Artificial Functional MaterialsNanjing UniversityNanjing 210023China State Key Laboratory of Analytical Chemistry for Life ScienceSchool of Chemistry and Chemical EngineeringChemistry and Biomedicine Innovation Center(ChemBIC)Nanjing UniversityNanjing 210023China 

出 版 物：《Science China(Life Sciences)》 (中国科学（生命科学英文版）)

年 卷 期：2021年第64卷第8期

页      面：1368-1371页

核心收录：

学科分类：1002[医学-临床医学] 08[工学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 082203[工学-发酵工程] 0822[工学-轻工技术与工程] 10[医学] 

基　　金：supported by the National Key Research and Development Program of China(2019YFA0709200) Natural Science Foundation of Jiangsu Province(BK20180340) the National Natural Science Foundation of China(21722503,21874067) CAS Interdisciplinary Innovation Team(JCTD-2020-08) PAPD program,the Innovation Foundation of Nanjing University,and Fundamental Research Funds for the Central Universities(021314380145) 

主　　题：diseases vivo 

摘      要：Nanozymes,the functional nanomaterials with enzyme-like activities,have been widely explored for both in vitro and in vivo applications(Wei and Wang,2013;Wu et al.,2019;Huang et al.,2019;Liang and Yan,2019).Particularly,by modulating the levels of reactive oxygen species(ROS)in vivo,numerous therapeutic nanozymes have been developed to treat diseases,ranging from cancer to neurodegenerative diseases(Fan et al.,2018;Kwon et al.,2018).